PL1865966T3 - Zastosowanie niesteroidowych leków przeciwzapalnych do inhalacji w leczeniu ostrego i chronicznego zapalenia oskrzeli - Google Patents

Zastosowanie niesteroidowych leków przeciwzapalnych do inhalacji w leczeniu ostrego i chronicznego zapalenia oskrzeli

Info

Publication number
PL1865966T3
PL1865966T3 PL06707521T PL06707521T PL1865966T3 PL 1865966 T3 PL1865966 T3 PL 1865966T3 PL 06707521 T PL06707521 T PL 06707521T PL 06707521 T PL06707521 T PL 06707521T PL 1865966 T3 PL1865966 T3 PL 1865966T3
Authority
PL
Poland
Prior art keywords
inhalation
acute
treatment
steroidal anti
inflammatory drugs
Prior art date
Application number
PL06707521T
Other languages
English (en)
Inventor
Josè Sebastian Franzone
Sebastiano Bianco
Giuseppe Zuccari
Claudio Franco Omini
Original Assignee
Medestea Res & Production S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36353659&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1865966(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medestea Res & Production S P A filed Critical Medestea Res & Production S P A
Publication of PL1865966T3 publication Critical patent/PL1865966T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL06707521T 2005-03-15 2006-03-10 Zastosowanie niesteroidowych leków przeciwzapalnych do inhalacji w leczeniu ostrego i chronicznego zapalenia oskrzeli PL1865966T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI20050417 ITMI20050417A1 (it) 2005-03-15 2005-03-15 Uso di farmaci anti-infiammatori non steroidei per via inalatoria nella terapia della bronchite acuta e cronica
PCT/EP2006/002226 WO2006097247A1 (en) 2005-03-15 2006-03-10 The use of non-steroidal anti-inflammatory drugs by inhalation in the treatment of acute and chronic bronchitis
EP06707521A EP1865966B1 (en) 2005-03-15 2006-03-10 The use of non-steroidal anti-inflammatory drugs by inhalation in the treatment of acute and chronic bronchitis

Publications (1)

Publication Number Publication Date
PL1865966T3 true PL1865966T3 (pl) 2010-03-31

Family

ID=36353659

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06707521T PL1865966T3 (pl) 2005-03-15 2006-03-10 Zastosowanie niesteroidowych leków przeciwzapalnych do inhalacji w leczeniu ostrego i chronicznego zapalenia oskrzeli

Country Status (15)

Country Link
US (1) US9132109B2 (pl)
EP (1) EP1865966B1 (pl)
JP (1) JP5175710B2 (pl)
CN (1) CN101163484B (pl)
AR (1) AR053032A1 (pl)
AT (1) ATE446760T1 (pl)
BR (1) BRPI0609827A2 (pl)
CA (1) CA2601137A1 (pl)
DE (1) DE602006010042D1 (pl)
ES (1) ES2332530T3 (pl)
IT (1) ITMI20050417A1 (pl)
PL (1) PL1865966T3 (pl)
PT (1) PT1865966E (pl)
RU (1) RU2408376C2 (pl)
WO (1) WO2006097247A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008004386A1 (de) * 2008-01-14 2009-07-23 Activaero Gmbh Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757529B2 (en) * 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
AU2013388034B2 (en) * 2013-04-30 2019-08-15 Aspeya US Inc. Dry powder formulations and methods of use
CN112656780A (zh) * 2014-02-20 2021-04-16 奥迪托皮克股份有限公司 用于吸入的干粉制剂
TWI586383B (zh) * 2014-04-18 2017-06-11 林信湧 一種用於治療關節炎之吸入式醫藥組成物及其備製方法
CN111346100A (zh) * 2020-04-16 2020-06-30 四川大学华西医院 阿司匹林或其衍生物在制备治疗气道粘液高分泌的药物中的用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE179605T1 (de) * 1991-02-09 1999-05-15 B S D Bio Science Dev Snc Di O Antireaktive antiasthmatische wirkung von acetylsalicylsäure durch inhalation
EP0499143B1 (en) 1991-02-09 1999-05-06 B.S.D. BIO SCIENCE DEVELOPMENT SNC Di OMINI C. & ZUCCARI G. Anti-reactive anti-asthmatic activity of acetylsalicylic acid by inhalation
US5883084A (en) * 1998-06-08 1999-03-16 Clarion Pharmaceuticals Inc. Treatment of respiratory diseases utilizing α-tocopheryl-phosphocholine
DE19900233A1 (de) * 1999-01-07 2000-07-13 Moeller Plast Gmbh Verfahren zur Herstellung eines hochbelastbaren Bauteils aus Kunststoff und hochbelastbares Bauteil
US20020147216A1 (en) 2000-01-31 2002-10-10 Yuhong Zhou Mucin synthesis inhibitors
US20030017150A1 (en) * 2001-03-14 2003-01-23 Torphy Theodore J. Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses
JP2003221335A (ja) * 2001-10-26 2003-08-05 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
AU2004264941B2 (en) * 2003-08-11 2008-11-27 Glaxo Group Limited Pharmaceutical metered dose inhaler and methods relating thereto
CA2536293A1 (en) 2003-08-22 2005-03-03 Boehringer Ingelheim Pharmaceuticals, Inc. Methods of treating copd and pulmonary hypertension

Also Published As

Publication number Publication date
JP5175710B2 (ja) 2013-04-03
DE602006010042D1 (de) 2009-12-10
ATE446760T1 (de) 2009-11-15
ITMI20050417A1 (it) 2006-09-16
RU2007138033A (ru) 2009-04-20
EP1865966A1 (en) 2007-12-19
CA2601137A1 (en) 2006-09-21
PT1865966E (pt) 2009-11-26
RU2408376C2 (ru) 2011-01-10
US9132109B2 (en) 2015-09-15
ES2332530T3 (es) 2010-02-08
EP1865966B1 (en) 2009-10-28
JP2008533071A (ja) 2008-08-21
US20080306033A1 (en) 2008-12-11
BRPI0609827A2 (pt) 2010-04-27
AR053032A1 (es) 2007-04-18
WO2006097247A1 (en) 2006-09-21
CN101163484B (zh) 2010-09-29
CN101163484A (zh) 2008-04-16

Similar Documents

Publication Publication Date Title
CR8642A (es) Compuestos, composiciones farmaceuticas y metodos para su uso en el tratameinto de desordenes metabolicos
PT1765314T (pt) Composições farmacêuticas para o tratamento de doenças e sintomas em artrite reumatoide
PL2468290T3 (pl) Antagoniści aktywiny-ActRII do stosowania w leczeniu niedokrwistości
PL2037902T3 (pl) Zastosowanie kanabidiolu w użyciu w leczeniu bólu neuropatycznego
SI2084151T1 (sl) Substituirani dihidropirazoloni za zdravljenje kardiovaskularnih in hematoloških bolezni
IL188732A (en) Use of ibuprofen and famotidine in the preparation of medicaments
EP2019825A4 (en) HEMMER OF THE REPRODUCTION OF HUMAN IMMUNE DEFICIENCY VIRUSES
PL2252283T3 (pl) Syntetyczne triterpenoidy i sposoby zastosowania w leczeniu choroby
ME01814B (me) Citotoksični agensi koji sadrže nove derivate tomaimicina i njihova terapeutska primjena
ZA200806114B (en) Use of sulfonamide derivatives in the treatment of disorders of the metabolism and the nervous system
BRPI0913822A2 (pt) forma farmacêutica oral e uso da forma farmacêutica
ZA200902419B (en) Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases
EP2114413A4 (en) THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER USING 3-BROMOPYRUVATE AND OTHER SELECTIVE INHIBITORS OF ATP PRODUCTION
PT2054045E (pt) Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento da artrite e da dor
EP2123266A4 (en) THERAPEUTIC CANCER AND ANTI-CARCINOGENIC AGENT
BRPI0810475A2 (pt) uso de dimiracetam no tratamento de dor crônica
ZA200709830B (en) Synergistic combinations of non-steroidal anti-inflammatory drugs with alpha-delta-ligands
NO20070892L (no) Sammensetninger av N-glykolylneuraminsyre og anvendelse derav ved behandling av forkjølelse.
PT2982372T (pt) Agentes moduladores do glutamato no tratamento de distúrbios mentais
BRPI0806529A2 (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto, e, método de tratamento de um distúrbio de agregação de plaqueta
DK1773796T3 (da) Oxopiperidinderivater, fremstilling deraf samt terapeutisk anvendelse deraf
IL195155A (en) Dosage form for delayed glucocorticoid release and its use in the treatment of rheumatic diseases
PL1865966T3 (pl) Zastosowanie niesteroidowych leków przeciwzapalnych do inhalacji w leczeniu ostrego i chronicznego zapalenia oskrzeli
ATE420081T1 (de) Trifluormethylbenzamidderivate und therapeutische verwendungen dafür
PL377180A1 (pl) Zastosowanie izoflawonów i ich pochodnych w leczeniu mukopolisacharydoz